CombiMatrix Corp, Irvine, Calif, a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental disorders, has entered into a contractual agreement with Fortified Provider Network (FPN) for coverage of CombiMatrix’s suite of diagnostic laboratory services.

CombiMatrix specializes in miscarriage analysis, prenatal testing, and pediatric genetics, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies.


Mark McDonough, CombiMatrix

FPN has more than 200 payor clients nationwide and contracts with physicians, hospitals, ancillary facilities, mid-level providers, and other specialty healthcare providers who have the option of participating in one or more of their products (eg, group health, workers compensation, or auto liability).

“Our contract with Fortified Provider Network is a result of our continued focus on executing our third-party payor strategy to deliver microarray technologies to doctors and patients nationwide,” says Mark McDonough, CombiMatrix President and CEO. “This contract enables us to offer our suite of diagnostic services, including CombiSNP microarray analysis, to the members of FPN, whose ultimate goal is to ensure that the end-user patients are able to receive excellent care in the location of their choice from high-quality providers, all at a cost that is both acceptable and attractive to their payor clients and providers.

“We have invested in payor relations over the past few months,” adds McDonough. “Securing the Fortified Provider Network contract is of significant benefit to us, and validates that our strategy is taking hold.”

For further information, visit CombiMatrix.